TickerFactsScreenerDevelopers

Merck & Co., Inc. (MRK) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2006: $5.91B2007: $5.34B2008: $4.37B2009: $9.31B2010: $10.90B2011: $13.53B2012: $13.45B2013: $15.62B2014: $7.44B2015: $8.52B2016: $6.51B2017: $6.09B2018: $7.96B2019: $9.68B2020: $8.05B2021: $8.10B2022: $12.69B2023: $6.84B2024: $13.24B2025: $14.56B$14.56B
2006Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$14.56B+10.0%
2024$13.24B+93.6%
2023$6.84B-46.1%
2022$12.69B+56.8%
2021$8.10B+0.6%
2020$8.05B-16.8%
2019$9.68B+21.5%
2018$7.96B+30.7%
2017$6.09B-6.5%
2016$6.51B-23.6%
2015$8.52B+14.6%
2014$7.44B-52.4%
2013$15.62B+16.1%
2012$13.45B-0.6%
2011$13.53B+24.1%
2010$10.90B+17.1%
2009$9.31B+113.2%
2008$4.37B-18.1%
2007$5.34B-9.8%
2006$5.91B—